Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection

Infection and Immunity

Volumn 76, Issue 7, 2008, Pages 3207-3213

  Rolán, Hortensia García ^a,b   Tsolis, Renée M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G2A; INTERLEUKIN 12P40; MUTANT PROTEIN; VIRB PROTEIN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUCELLOSIS; CD4+ T LYMPHOCYTE; CELL INTERACTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; POLARIZATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SPLEEN CELL; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; BLOOD; BRUCELLA ABORTUS; FEMALE; GENETICS; IMMUNITY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MUTATION; PATHOGENICITY; SECRETION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BRUCELLA ABORTUS; BRUCELLOSIS; CYTOKINES; FEMALE; IMMUNITY; MICE; MICE, INBRED BALB C; MUTATION; OPERON; TH1 CELLS; VIRULENCE FACTORS;

EID: 46449091814     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00203-08     Document Type: Article

References (44)

1. Agranovich, I., D. E. Scott, D. Terle, K. Lee, and B. Golding. 1999. Down-regulation of Th2 responses by Brucella abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway. Infect. Immun. 67:4418-4426.
2. Alton, G. G., L. M. Jones, and D. E. Pietz. 1975. Laboratory techniques in brucellosis. Monogr. Ser. World Health Organ. 1-163.
3. Araj, G. F. 1999. Human brucellosis: a classical infectious disease with persistent diagnostic challenges. Clin. Lab. Sci. 12:207-212.
4. Branden, L. J., and C. I Smith. 2002. Bioplex technology: novel synthetic gene delivery system based on peptides anchored to nucleic acids. Methods Enzymol. 346:106-124.
5. Caron, E., T. Peyrard, S. Kohler, S. Cabane, J. P. Liautard, and J. Dornand. 1994. Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect. Immun. 62:5267-5274.
6. Celli, J., C. de Chastellier, D. M. Franchini, J. Pizarro-Cerda, E. Moreno, and J. P. Gorvel. 2003. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198:545-556.
7. Celli, J., S. P. Salcedo, and J. P. Gorvel. 2005. Brucella coopts the small GTPase Sar1 for intracellular replication. Proc. Natl. Acad. Sci. USA 102: 1673-1678.
8. Comerci, D. J., M. J. Martinez-Lorenzo, R. Sieira, J. P. Gorvel, and R. A. Ugalde. 2001. Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole. Cell. Microbiol. 3:159-168.
9. Delrue, R. M., M. Martinez-Lorenzo, P. Lestrate, I. Danese, V. Bielarz, P. Mertens, X. De Bolle, A. Tibor, J. P. Gorvel, and J. J. Letesson. 2001. Identification of Brucella spp. genes involved in intracellular trafficking. Cell. Microbiol. 3:487-497.
10. den Hartigh, A. B., Y. H. Sun, D. Sondervan, N. Heuvelmans, M. O. Reinders, T. A. Ficht, and R. M. Tsolis. 2004. Differential requirements for VirB1 and VirB2 during Brucella abortus infection. Infect. Immun. 72:5143-5149.
11. Dornand, J., A. Gross, V. Lafont, J. Liautard, J. Oliaro, and J. P. Liautard. 2002. The innate immune response against Brucella in humans. Vet. Microbiol. 90:383-394.
12. Fernandes, D. M., and C. L. Baldwin. 1995. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect. Immun. 63:1130-1133.
13. Fernandez-Lago, L., M. Monte, and A. Chordi. 1996. Endogenous gamma interferon and interleukin-10 in Brucella abortus 2308 infection in mice. FEMS Immunol. Med. Microbiol. 15:109-114.
14. Fernandez-Lago, L., E. Rodriguez-Tarazona, and N. Vizcaino. 1999. Differential secretion of interleukin-12 (IL-12) subunits and heterodimerrc IL-12p70 protein by CD-1 mice and murine macrophages in response to intracellular infection by Brucella abortus. J. Med. Microbiol. 48:1065-1073.
15. Fretin, D., A. Fauconnier, S. Kohler, S. Hailing, S. Leonard, C. Nijskens, J. Ferooz, P. Lestrate, R. M. Delrue, I. Danese, J. Vandenhaute, A. Tibor, X. DeBolle, and J. J. Letesson. 2005. The sheathed flagellum of Brucella melitensis is involved in persistence in a murine model of infection. Cell. Microbiol. 7:687-698.
16. Guillemin, K., N. R. Salama, L. S. Tompkins, and S. Falkow. 2002. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 99:15136-15141.
17. Hong, P. C., R. M. Tsolis, and T. A. Ficht. 2000. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 68:4102-4107.
18. Hort, G. M., J. Weisenburger, B. Borsdorf, C. Peters, M. Banai, H. Hahn, J. Jacob, and M. E. Mielke. 2003. Delayed type hypersensitivity- associated disruption of splenic periarteriolar lymphatic sheaths coincides with temporary loss of IFN-gamma production and impaired eradication of bacteria in Brucella abortus-infected mice. Microbes Infect. 5:95-106.
19. Hsieh, C. S., S. E. Macatonia, C. S. Tripp, S. F. Wolf, A. O'Garra, and K. M. Murphy. 1993. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549.
20. Kahl-McDonagh, M. M., P. H. Elzer, S. D. Hagius, J. V. Walker, Q. L. Perry, C. M. Seabury, A. B. den Hartigh, R. M. Tsolis, L. G. Adams, D. S. Davis, and T. A. Ficht. 2006. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis. Vaccine 24:5169-5177.
21. Kahl-McDonagh, M. M., and T. A. Ficht. 2006. Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice. Infect. Immun. 74:4048-4057.
22. Lestrate, P., R. M. Delrue, I. Danese, C. Didembourg, B. Taminiau, P. Mertens, X. De Bolle, A. Tibor, C. M. Tang, and J. J. Letesson. 2000. Identification and characterization of in vivo attenuated mutants of Brucella melitensis. Mol. Microbiol. 38:543-551.
23. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
24. Molofsky, A. B., B. G. Byrne, N. N. Whitfield, C. A. Madigan, E. T. Fuse, K. Tateda, and M. S. Swanson. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203: 1093-1104.
25. Murphy, E. A., J. Sathiyaseelan, M. A. Parent, B. Zou, and C. L. Baldwin. 2001. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 103:511-518.
26. Overbergh, L., A. Giulietti, D. Valckx, R. Decallonne, R. Bouillon, and C. Mathieu. 2003. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J. Biomol. Tech. 14:33-43.
27. Pasquali, P., R. Adone, L. C. Gasbarre, C. Pistoia, and F. Ciuchini. 2001. Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection. Infect. Immun. 69:6541-6544.
28. Rafiei, A., S. K. Ardestani, A. Kariminia, A. Keyhani, M. Mohraz, and A. Amirkhani. 2006. Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J. Infect. 53:315-324.
29. Ren, T., D. S. Zamboni, C. R. Roy, W. F. Dietrich, and R. E. Vance. 2006. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog. 2:e18.
30. Rieder, G., W. Fischer, and R. Haas. 2005. Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr. Opin. Microbiol. 8:67-73.
31. Rolan, H. G., and R. M. Tsolis. 2007. Mice lacking components of adaptive immunity show increased Brucella abortus virB mutant colonization. Infect. Immun. 75:2965-2973.
32. Roux, C. M., H. G. Rolan, R. L. Santos, P. D. Beremand, T. L. Thomas, L. G. Adams, and R. M. Tsolis. 2007. Brucella requires a functional type IV secretion system to elicit innate immune responses in mice. Cell. Microbiol. 9:1851-1869.
33. Sathiyaseelan, J., R. Goenka, M. Parent, R. M. Benson, E. A. Murphy, D. M. Fernandes, A. S. Foulkes, and C. L. Baldwin. 2006. Treatment of Brucella- susceptible mice with IL-12 increases primary and secondary immunity. Cell. Immunol. 243:1-9.
34. Schmid, M. C., F. Scheidegger, M. Dehio, N. Balmelle-Devaux, R. Schulein, P. Guye, C. S. Chemmakesava, B. Biedermann, and C. Dehio. 2004. The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol. Microbiol. 52:141-147.
35. Sieira, R., D. J. Comerci, D. O. Sanchez, and R. A. Ugalde. 2000. A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication. J. Bacteriol. 182:4849-4855.
36. Sporri, R., N. Joller, U. Albers, H. Hilbi, and A. Oxenius. 2006. MyD88-dependent IFN-gamma production by NK cells is key for control of Legionella pneumophila infection. J. Immunol. 176:6162-6171.
37. Stinebring, W. R., and J. S. Youngner. 1964. Patterns of interferon appearance in mice infected with bacteria or bacterial endotoxin. Nature 204:712.
38. Sun, Y. H., A. B. den Hartigh, R. L. Santos, L. G. Adams, and R. M. Tsolis. 2002. virB-mediated survival of Brucella abortus in mice and macrophages is independent of a functional inducible nitric oxide synthase or NADPH oxidase in macrophages. Infect. Immun. 70:4826-4832.
39. Sun, Y. H., H. G. Rolan, A. B. den Hartigh, D. Sondervan, and R. M. Tsolis. 2005. Brucella abortus virB12 is expressed during infection but is not an essential component of the type IV secretion system. Infect. Immun. 73:6048-6054.
40. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796-3806.
41. Vendrell, J. P., A. Delobbe, M. F. Huguet, F. Peraldi, A. Serre, and A. Cannat. 1987. Biological properties of a panel of murine monoclonal anti-Brucella antibodies. Immunology 61:7-10.
42. Viala, J., C. Chaput, I. G. Boneca, A. Cardona, S. E. Girardin, A. P. Moran, R. Athman, S. Memet, M. R. Huerre, A. J. Coyle, P. S. DiStefano, P. J. Sansonetti, A. Labigne, J. Bertin, D. J. Philpott, and R. L. Ferrero. 2004. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5:1166-1174.
43. Young, E. 2000. Mandell, Douglas, and Bennett's principles and practice of infectious disease, vol. 2. Churchill Livingstone, Philadelphia, PA.
44. Zhan, Y., and C. Cheers. 1993. Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect. Immun. 61:4899-4901.